Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
- Previous Close
2.3800 - Open
2.3700 - Bid 2.3700 x --
- Ask 2.3800 x --
- Day's Range
2.3700 - 2.4300 - 52 Week Range
2.2300 - 2.8900 - Volume
146,798,260 - Avg. Volume
67,859,592 - Market Cap (intraday)
20.93B - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
14.81 - EPS (TTM)
0.1600 - Earnings Date --
- Forward Dividend & Yield 0.05 (1.89%)
- Ex-Dividend Date Jun 7, 2023
- 1y Target Est
--
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Leshan, China.
www.hebang.cnRelated News
Performance Overview: 603077.SS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603077.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603077.SS
Valuation Measures
Market Cap
21.02B
Enterprise Value
19.10B
Trailing P/E
14.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.31
Price/Book (mrq)
1.06
Enterprise Value/Revenue
2.13
Enterprise Value/EBITDA
11.26
Financial Highlights
Profitability and Income Statement
Profit Margin
15.57%
Return on Assets (ttm)
4.25%
Return on Equity (ttm)
7.03%
Revenue (ttm)
8.98B
Net Income Avi to Common (ttm)
1.4B
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
3.88B
Total Debt/Equity (mrq)
9.62%
Levered Free Cash Flow (ttm)
494.89M